Research analysts at HC Wainwright issued their FY2029 EPS estimates for Edap Tms in a research note issued to investors on Friday, March 28th. HC Wainwright analyst S. Ramakanth anticipates that the ...

Q4 2024 Earnings Call Transcript March 27, 2025 EDAP TMS S.A. beats earnings expectations. Reported EPS is $-0.05, ...

Full Year 2024 Results Key Financial Results Revenue: €64.1m (up 6.1% from FY 2023). Net ...

Piper Sandler lowered the firm’s price target on EDAP TMS (EDAP) to $4.50 from $5 and keeps an Overweight rating on the shares. The firm notes ...

Depression affects about one in 20 adults, and while treatments like antidepressants and talk therapy help many people, they ...

Edap TMS SA (EDAP) reports robust HIFU revenue growth and strategic advancements, despite facing operational challenges and a ...

Piper Sandler analyst Jason Bednar maintained a Buy rating on EDAP TMS (EDAP – Research Report) today and set a price target of $4.50. The ...

The Horizon 3.0 TMS Therapy System is a computerized, noninvasive medical device that directs electrical currents at different regions of the cerebral cortex.

Neuronetics' strategic acquisitions, including Greenbrook, and FDA approvals are expected to drive revenue growth. See why ...

Analysts estimate that Edap TMS will report an earnings per share (EPS) of $-0.12. Edap TMS bulls will hope to hear the ...

Neuronetics, Inc. (NASDAQ: STIM) has updated its financial results for the fourth quarter and full-year ending December 31, ...

Edap Tms (NASDAQ:EDAP – Free Report) had its price target lowered by Piper Sandler from $5.00 to $4.50 in a research note published on Friday,Benzinga reports. The brokerage currently has an ...